pfizer pharma news - Search News

Pfizer, Starboard

The Motley Fool · 21h

An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock

On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -2.82%) that's worth approximately $1 billion. Now, Starboard will aim to work with the company's management as well as consult with former executives -- all with the aim of turning around Pfizer's sagging fortunes.

MarketWatch on MSN · 1d

Pfizer’s stock dips after two former execs say they won’t support Starboard

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.

GlobalData on MSN · 17h

Activist investor Starboard cries foul play in exec U-turn at Pfizer

Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.

FDA, Pfizer and hemophilia

FiercePharma · 13h

Pfizer doubles down with its 2nd FDA hemophilia approval in 6 months

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA approved a Pfizer treatment for hemophilia. On Friday the U.S. regulator signed off on Hympavzi,

UPI News on MSN · 13h

FDA approves first once-weekly drug treatment regimen for hemophilia

Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first once-weekly treatment for the disease.

The Wall Street Journal on MSN · 15h

Pfizer’s Hympavzi Approved for Treatment of Certain Types of Hemophilia

The FDA approved Pfizer’s Hympavzi, which can be an alternative to intravenous infusions often administered multiple times a week.

3m

2 Incredibly Cheap Big Pharma Stocks to Buy Now

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Activist investor takes $1B stake in Pfizer, aims to turn around company

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

4d

Pfizer: A Strong Product Pipeline Could Lead To Significant Upside

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

1don MSN

Pfizer fight with Starboard heats up, hedge fund alleges executive pressure

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results